Survivin Positivity and Prognostic Factors in Papillary Thyroid Carcinomas | Zendy

E Usturali Keskin | Zendy; Ebru Taştekin | Zendy; Nuray Can | Zendy; Ayşe Nur Usturalı Mut | Zendy; Mehmet Çelik | Zendy; Buket Yılmaz Bülbül | Zendy; Fulya Öz Puyan | Zendy; Filiz Özyılmaz | Zendy; Semra Güldiken | Zendy; Semra Aytürk | Zendy; Ahmet Sezer | Zendy; Funda Üstün | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Survivin Positivity and Prognostic Factors in Papillary Thyroid Carcinomas

Author(s) -

E Usturali Keskin,

Ebru Taştekin,

Nuray Can,

Ayşe Nur Usturalı Mut,

Mehmet Çelik,

Buket Yılmaz Bülbül,

Fulya Öz Puyan,

Filiz Özyılmaz,

Semra Güldiken,

Semra Aytürk,

Ahmet Sezer,

Funda Üstün

Publication year - 2021

Publication title -

acta endocrinologica (bucharest)

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.249

H-Index - 13

eISSN - 1843-066X

pISSN - 1841-0987

DOI - 10.4183/aeb.2021.455

Subject(s) - survivin , medicine , immunohistochemistry , stromal cell , pathology , lymph node , lymphovascular invasion , thyroid carcinoma , thyroid , cancer research , oncology , cancer , metastasis

Papillary thyroid carcinoma(PTC)s are the indolent progressive tumours. Survivin is a unique bifunctional protein with cell cycle regulation and apoptosis inhibition. The expression of this protein has been shown to be increased in thyroid tumours correlated with aggressive behavior from well differentiated to anaplastic.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research